SCIENTIFIC EVIDENCE

Ginsenoside Rg1 as a promising adjuvant agent for enhancing the anti-cancer functions of granulocytes inhibited by noradrenaline

Frontiers in Immunology
Yuqian Zhu, Jingyao Chen, Jun Li, Chenqi Zhou, Xin Huang, Bingdi Chen

Publication Overview

Key findings, Countstar context, and access to the original paper.
2023
Cell Counting & Viability
Single-Cell Analysis
No items found.
Key Finding
This study assessed ginsenoside Rg1 as an adjuvant for granulocyte-mediated anti-cancer activity under noradrenaline suppression. The authors report that Rg1 improved selected granulocyte anti-tumour functions and migration-related responses in their experimental models.
Countstar Connection
Counted granulocytes for a Transwell cell-migration assay.
Stay Connected toCountstar Science
Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.
Meet us online